This is a multi-center, randomized, double-blind, placebo-controlled study where participants will receive either a carbetocin nasal spray or a placebo nasal spray three times a day to evaluate the efficacy of treatment in people with Prader-Willi syndrome (PWS). For more information, please email Allison Bernique and Kiana Summers at CompassPWS@childrens.harvard.edu, or call 617-919-7678 or 617-919-5365.
Learn about the Compass PWS study.